[1] |
Ding ZY, Zhou L, Liu YM, et al. Safety and effi cacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: a multi-center prospective study[J]. Thoracic Cancer,2013,4(1):14-9.
|
[2] |
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2):228-47.
|
[3] |
The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[J]. J Natl Cancer Inst,1999,91(1):66-72.
|
[4] |
Gridelli C, Perrone F, Gallo C. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the Elderly Study (MILES) phase Ⅲ randomized trial[J]. J Natl Cancer Inst,2003,95(5):362-72.
|
[5] |
E Quoix,G Zalcman,JP Oster,et al.Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial[J].Lancet,2011,378(9796): 10 79-88.
|
[6] |
Abe T,Yokoyama A,Takeda K, et al. Randomized phase Ⅲ trial comparing weekly docetaxel(D)-cisplatin(P) combination with triweekly D alone in elderly patients(pts) with advance non-small cell lung cancer(NSCLC): an intergroup tiral of JCOG0803/ WJOG4307L [J]. J Clin Oncol, 2011,29:7509.
|
[7] |
Zheng Z, Chen T, Li X, et al. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer[J]. N Engl J Med,2007,356(8):800-8.
|
[8] |
Hasenclever D,Diehl V.A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin‘s Disease[J]. N Engl J Med,1998,339(21):1506-14.
|
[9] |
Hoff CM.Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy[J]. Acta Oncol,2012,51(4):419-32.
|
[10] |
Zhang HQ,Wang RB, Yan HJ, et al. Prognostic significance of CYFRA21-1,CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy[J]. Asian Pac J Cancer Prev,2012, 13(1):199-203.
|
[11] |
Walter CJ, Bell LT, Parsons SR, et al. Prevalence and signifi cance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma[J].Colorectal Dis,2012,15(1):52-6.
|
[12] |
Holgersson G,Sandelin M,Hoye E,et al.Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer[J]. Med Oncol,2012,29(5):3167-82.
|
[13] |
Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index[J]. Blood,2004,104(5):1258-65.
|
[14] |
Kim WY, Perera S, Zhou B, et al. HIF2α cooperates with RAS to promote lung tumorigenesis in mice[J]. J Clin Invest,2009,119(8): 21 60-70.
|